Atrium divests chemicals division
This article was originally published in The Tan Sheet
Executive Summary
Health and nutrition product marketer Atrium has completed the sale of its active ingredients and specialty chemicals division to Unipex Group for $166.4 million in cash, "subject to post-closing working capital adjustment," the company announces May 22. Proceeds will provide the firm better financial flexibility to pursue its corporate strategy, the Quebec City, Canada-based company notes. With the sale, Atrium has reached its goal of focusing entirely on health and nutrition products (1"The Tan Sheet" Jan. 6, 2008, In Brief)...